Skip to main content
. 2018 Jun 29;12:430. doi: 10.3389/fnins.2018.00430

FIGURE 3.

FIGURE 3

The concentrations of Gal-3 in serum (ng/mL) of ALS patients and healthy controls. ALS patients showed enhanced Gal-3 concentrations in serum as compared to the healthy controls (ALS vs. healthy controls [mean ± SD] 10.45 ± 3.48 vs. 8.76 ± 3.03 ng/mL; P = 0.019).